Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Electrophysiology (EP) is the study of the mechanism, function and performance of electrical signaling pathways that guide the functioning of the heart. EP study is a procedure that is performed to diagnose arrhythmias by locating areas of heart tissue that interrupt the normal functioning of the heart's electrical system. During an EP study, the electrophysiologist inserts several long, flexible tubes with wires, called catheters, into the heart to record electrical activity within the heart chambers and to detect abnormal electrical pathways. The second part of the test involves electrical stimulation of various parts of the heart to induce an abnormal heart rhythm. This helps the electro physiologist in treatment mapping, which could involve surgical removal of the abnormal tissue in the heart using a catheter.
Global EP Catheter Ablation includes Johnson & Johnson and Abbott, etc. Global top two companies hold a share over 70%. North America is the largest market, with a share about 33%, followed by Europe and Asia-Pacific with the share about 30% and 29%.
The global EP Catheter Ablation market was valued at US$ 1228 million in 2020 and is expected to reach US$ 2471.2 million by the end of 2027, growing at a CAGR of 10.7% during 2021-2027.
This report focuses on EP Catheter Ablation volume and value at the global level, regional level and company level. From a global perspective, this report represents overall EP Catheter Ablation market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global EP Catheter Ablation Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Radiofrequency Ablation Catheters
Cryoablation EP Catheters
Segment by Application
Atrial Fibrillation (AF)
Ventricular Tachycardia (VT)
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Johnson & Johnson
Abbott
Medtronic
Boston Scientific
Biotronik
Japan Lifeline
OSYPKA
MicroPort EP MedTech
CardioFocus
Global EP Catheter Ablation includes Johnson & Johnson and Abbott, etc. Global top two companies hold a share over 70%. North America is the largest market, with a share about 33%, followed by Europe and Asia-Pacific with the share about 30% and 29%.
The global EP Catheter Ablation market was valued at US$ 1228 million in 2020 and is expected to reach US$ 2471.2 million by the end of 2027, growing at a CAGR of 10.7% during 2021-2027.
This report focuses on EP Catheter Ablation volume and value at the global level, regional level and company level. From a global perspective, this report represents overall EP Catheter Ablation market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global EP Catheter Ablation Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Radiofrequency Ablation Catheters
Cryoablation EP Catheters
Segment by Application
Atrial Fibrillation (AF)
Ventricular Tachycardia (VT)
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Johnson & Johnson
Abbott
Medtronic
Boston Scientific
Biotronik
Japan Lifeline
OSYPKA
MicroPort EP MedTech
CardioFocus
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
